Our findings here elucidate functional impairments of two patients with schizophrenia-derived CaMKII mutations on holoenzyme formation, GluN2B binding, synaptic targeting, and kinase activity and provide insight into the role of CaMKII dysregulation in neuropsychiatric disease. The gene discussed is CAMK2G; the disease is schizophrenia.